[Thalidomide and others: new treatment for myeloma].
Malphettes
Marion
M
Service d'immuno-hématologie, hôpital Saint-Louis, Paris. marionmalphettes@yahoo.fr
Fermand
Jean-Paul
JP
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D003546:Cysteine Endopeptidases / Q000494:pharmacology; D006801:Humans; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009101:Multiple Myeloma / Q000188:drug therapy*; D046988:Proteasome Endopeptidase Complex; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D009097:Multienzyme Complexes; D013792:Thalidomide; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex